Skip to main content
. 1998 Mar;72(3):2439–2448. doi: 10.1128/jvi.72.3.2439-2448.1998

FIG. 9.

FIG. 9

HIV-1-specific CTL induction by HIV-1 peptide 240–249. PBMC of patient 2 (HLA-B5801 positive) were stimulated either with HIV-1 Gag peptide 240–249 or HIV-2 Gag peptide 235–252 for 7 days and then tested against HLA-B5801-positive target cells infected with rVV expressing unrelated, HIV-2, and HIV-1 A2 Gag proteins as described in Materials and Methods.